Linq COPD
Research payments
$830,961
Through program year 2024, $830,961 in research payments was reported against Linq COPD, across 162 payments.
- Paid by (largest first)
- Medtronic, Inc.; Medtronic Vascular, Inc.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
5 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2024 | Research | $2,000 | 1 |
| 2023 | Research | $141,018 | 57 |
| 2022 | Research | $267,091 | 50 |
| 2021 | Research | $398,374 | 46 |
| 2020 | Research | $22,479 | 8 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
8 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Shakeel Amanullah Lancaster, PA Named on 42 payments
- Jose Diaz Leesburg, FL Named on 22 payments
- Stephen Mester Brandon, FL Named on 13 payments
- Juan Pulido Jacksonville Beach, FL Named on 12 payments
- Gerard Criner Philadelphia, PA Named on 8 payments
- Loan Nguyen Oklahoma City, OK Named on 8 payments
- Meilan Han Ann Arbor, MI Named on 6 payments
- Philip Diaz Columbus, OH Named on 6 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.